Wijaya, Christian Julius, Hartono, Sandy Budi, Putro, Jindrayani Nyoo, Anggono, Juliana, Sembiring, Tarzan, Putra, Herlian E, Yuliana, Maria, Lie, Jenni, Santoso, Shella Permatasari, Chen, Chien-Yen, Soetaredjo, Felycia Edi, Ismadji, Suryadi and Gunawan, Setiyo Cellulose nanocrystals/zeolitic imidazolate framework-L (CNCs/ZIF-L) composites for loading and diffusion-controlled release of doxorubicin hydrochloride. Journal of The Taiwan Institute of Chemical Engineers. ISSN 18761070 (Unpublished)
![]() |
Text (Artikel)
2. Cellulose nanocrystals.pdf Download (4MB) |
Abstract
Background: Zeolitic imidazolate framework-L (ZIF-L) has great potential as a doxorubicin hydrochloride (DOX) drug carrier for oral chemotherapy applications. This medical application will greatly support the development of cancer treatment and reduce the cancer fatality rate. However, ZIF-L as a type of metal-organic framework (MOFs) faces several challenges to be implemented in biomedical applications which impact the drug loading and release mechanisms. Methods: CNCs/ZIF-L composites were fabricated via a green in-situ method using CNCs mass percentages of 2.5, 5, 7.5, and 10 % of Zn(NO3)2⋅6H2O. All composites were tested for the DOX loading and release mechanisms and antioxidant activity. Significant findings: Here, the addition of CNCs enhances the DOX loading capacity of CNCs/ZIF-L composite up to 1508.91 ± 7.72 mg/g due to the presence of abundant active functional groups. In addition, the DOX release profile is another interesting potential that occurs through a diffusion-controlled release mechanism. This shows the ability of CNCs/ZIF-L composite to deliver drugs orally where DOX is released consistently at a certain concentration level for prolonged treatment. Moreover, the IC50 value of DOX@CNCs/ZIF-L drug reaching 480.21 mg/L proves that the effectiveness of DOX is maintained even though it is administered orally in the form of solid material.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | Cellulose nanocrystals Composite Doxorubicin hydrochloride Drug carrier Zeolitic imidazolate framework-L |
Subjects: | Engineering |
Depositing User: | Christine Limbara |
Date Deposited: | 06 May 2025 06:06 |
Last Modified: | 06 May 2025 06:06 |
URI: | https://repositori.ukwms.ac.id/id/eprint/43094 |
Actions (login required)
![]() |
View Item |